AUTOLUS THERAPEUTICS PLC - AMERICAN DEPOSITARY SHA

Autolus Therapeutics to Report First Quarter 2021 Financial Results and Host Conference Call on May 6

26 4月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Autolus Therapeutics Receives Innovation Passport and entry into ILAP for AUTO4 for the treatment of T cell receptor constant region beta chain 1 (TRBC1) positive T cell lymphomas

20 4月 2021 06:00:00 条件 Nasdaq GlobeNewswire

Autolus Therapeutics announces appointment of Martin Murphy as Non-executive Chairman

19 4月 2021 06:00:00 条件 Nasdaq GlobeNewswire

Autolus Therapeutics to Participate in Investor Conferences Through April

01 4月 2021 15:01:00 条件 Nasdaq GlobeNewswire

Autolus Therapeutics Receives PRIME designation for AUTO1 for the treatment of adult ALL

01 4月 2021 07:45:42 条件 Nasdaq GlobeNewswire

Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations

29 3月 2021 07:00:00 条件 Nasdaq GlobeNewswire

Autolus Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress

04 3月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Autolus Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference

24 2月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSs

12 2月 2021 15:01:00 条件 Nasdaq GlobeNewswire

Autolus Announces Pricing of Public Offering

09 2月 2021 19:42:36 条件 Nasdaq GlobeNewswire

Autolus Announces Proposed Public Offering in the United States

08 2月 2021 15:18:56 条件 Nasdaq GlobeNewswire

Autolus Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on March 4

04 2月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Autolus Therapeutics provides business outlook for 2021 & 2022

06 1月 2021 03:07:15 条件 Nasdaq GlobeNewswire

Autolus Therapeutics to participate in Investor Conferences through January

04 1月 2021 06:00:00 条件 Nasdaq GlobeNewswire